Role of lncRNAs as prognostic factor and potential therapeutic target in Multiple Myeloma

被引：1

作者：

Carrasco-Leon, Arantxa ^{[1
]}

Ezponda, Teresa ^{[1
]}

Meydan, Cem ^{[2
]}

Valcarcel, Luis Vitores ^{[3
]}

Ordonez, Raquel ^{[1
]}

Kulis, Marta ^{[4
]}

Garate, Leire ^{[1
]}

Miranda, Estibaliz ^{[1
]}

Segura, Victor ^{[5
]}

Guruceaga, Elisabeth ^{[5
]}

Vilas-Zornoza, Amaia ^{[1
]}

Alignani, Diego ^{[6
]}

Castro-Labrador, Laura ^{[1
]}

Pascual, Marien ^{[1
]}

Amundarain, Ane ^{[1
]}

El Omri, Halima ^{[7
]}

Taba, Ruba Y. ^{[7
]}

Calasanz, Maria-Jose ^{[8
]}

Planes, Francisco ^{[3
]}

Paiva, Bruno ^{[9
]}

Mason, Christopher E. ^{[2
]}

San-Miguel, Jesus ^{[10
]}

Martin-Subero, Jose I. ^{[4
]}

Melnick, Ari ^{[2
]}

Agirre, Xabier ^{[1
]}

Prosper, Felipe ^{[9
]}

机构：

[1] Univ Navarra, IDISNA, CIMA, Pamplona, Spain

[2] Weill Cornell Med Coll, New York, NY USA

[3] Tecnun Sch Engn, San Sebastian, Spain

[4] Univ Barcelona, Barcelona, Spain

[5] Univ Navarra, IDISNA, Dept Bioinformat, CIMA, Pamplona, Spain

[6] Univ Navarra, Flow Citometry Core, CIMA, Pamplona, Spain

[7] Hamad Med Corp, Natl Ctr Canc Care & Res, Doha, Qatar

[8] Univ Navarra, LAB Diagnost, CIMA, Pamplona, Spain

[9] Univ Navarra, CUN, CIMA, Pamplona, Spain

[10] Clin Univ Navarra, Pamplona, Spain

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

epigenetic; LncRNA; Transcriptomic Analysis;

D O I：

10.1016/j.clml.2019.09.585

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-301

引用

页码：E354 / E355

页数：2

共 50 条

[1] Characterization of Complete Lncrnas Transcriptome Reveals Expression of Lncrnas As a Prognostic Factor and Linc-Smilo As a Potential Therapeutic Target in Multiple Myeloma
Carrasco, Arantxa
Ezponda, Teresa
Meydan, Cem
Valcarcel, Luis Vitores
Ordonez, Raquel
Kulis, Marta
Garate, Leire
Miranda, Estibaliz
Segura, Victor
Guruceaga, Elizabeth
Vilas-Zornoza, Amaia
Alignani, Diego
Castro, Laura
Pascual, Marien
Amundarain, Ane
El Omri, Halima
Yasin, Ruba
Calasanz, Maria Jose
Planes, Francisco J.
Paiva, Bruno
Mason, Christopher
San-Miguel, Jesus
Subero, Inaki Martin
Melnick, Ari M.
Prosper, Felipe
Agirre, Xabier
BLOOD, 2019, 134
[2] JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
A G Solimando
A Brandl
K Mattenheimer
C Graf
M Ritz
A Ruckdeschel
T Stühmer
Z Mokhtari
M Rudelius
J Dotterweich
M Bittrich
V Desantis
R Ebert
P Trerotoli
M A Frassanito
A Rosenwald
A Vacca
H Einsele
F Jakob
A Beilhack
Leukemia, 2018, 32 : 736 - 743
[3] JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma
Solimando, Antonio
Brandl, Andreas
Katharina, Mattenheimer
Graf, Carolin
Ritz, Miriram
Ruckdeschel, Anna
Stuhmer, Thorsten
Rudelius, Martina
Frassanito, Maria Antonia
Andreas, Rosenwald
Jakob, Franz
Vacca, Angelo
Einsele, Hermann
Beilhack, Andreas
BLOOD, 2016, 128 (22)
[4] JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
Solimando, A. G.
Brandl, A.
Mattenheimer, K.
Graf, C.
Ritz, M.
Ruckdeschel, A.
Stuehmer, T.
Mokhtari, Z.
Rudelius, M.
Dotterweich, J.
Bittrich, M.
Desantis, V.
Ebert, R.
Trerotoli, P.
Frassanito, M. A.
Rosenwald, A.
Vacca, A.
Einsele, H.
Jakob, F.
Beilhack, A.
LEUKEMIA, 2018, 32 (03) : 736 - 743
[5] Indirubins: A Potential Therapeutic Target in Multiple Myeloma
Bagratuni, Tina
Gaboriad-Kolar, Nicolas
Zakopoulou, Roubini
Myrianthopoulos, Vassilios
Kastritis, Efstathios
Terpos, Evangelos
Mikros, Emmanuel
Skaltsounis, Alexios-Leandros
Dimopoulos, Meletios A.
BLOOD, 2016, 128 (22)
[6] Indirubins: A Potential Therapeutic Target in Multiple Myeloma
Bagratuni, Tina
Gaboriad-Kolar, Nicolas
Zakopoulou, Roubini
Myrianthopoulos, Vassilios
Kastritis, Efstathios
Terpos, Evangelos
Mikros, Emmanuel
Skaltsounis, Alexios-Leandros
Dimopoulos, Meletios Athanasios
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E40 - E41
[7] Junctional adhesion molecule-A as a prognostic factor and new therapeutic target in multiple myeloma
Solimando, A. G.
Brandl, A.
Mattenheimer, K.
Graf, C.
Ritz, M.
Ruckdeschel, A.
Stuehmer, T.
Mokhtari, Z.
Rudelius, M.
Da Via, M. C.
Bittrich, M.
Leone, P.
Ebert, R.
Racanelli, V
Kortuem, K. M.
Rosenwald, A.
Jakob, F.
Vacca, A.
Einsele, H.
Beilhack, A.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 244 - 245
[8] Role of Interleukin 16 in Multiple Myeloma Pathogenesis: A Potential Novel Therapeutic Target?
Mahindra, Anuj
Anderson, Kenneth C.
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (13) : 964 - 965
[9] Hedgehog pathway as a potential therapeutic target in multiple myeloma
Blotta, Simona
Negri, Joeseph
Nanjappa, Purushotharna
Moreau, Anne-Sophie
Prabhala, Rao
Shammas, Masood
Pelluru, Dheeraj
McMillin, Douglas
Tai, Yu-Tzu
Tassone, Pierfrancesco
Anderson, Kenneth C.
Mitsiades, Constantine
Munshi, Nilchil C.
BLOOD, 2007, 110 (11) : 206A - 207A
[10] The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma
Heimberger, Tanja
Andrulis, Mindaugas
Riedel, Simone
Stuehmer, Thorsten
Schraud, Heike
Beilhack, Andreas
Bumm, Thomas
Bogen, Bjarne
Einsele, Hermann
Bargou, Ralf C.
Chatterjee, Manik
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (04) : 465 - 476

← 1 2 3 4 5 →